Marathon Trading Investment Management LLC Black Diamond Therapeutics, Inc. Transaction History

Marathon Trading Investment Management LLC

$201 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	SELL	$4.65 - $7.39 $350,070 - $556,348	-75,284 Reduced 79.75%	19,116 $89,000
Q1 2024 May 10, 2024	BUY	$2.67 - $5.74 $252,048 - $541,856	94,400 New	94,400 $478,000

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

T. Rowe Price Investment Management, Inc. Baltimore, MD

10.7M
Shares

$23.8 Million
0.03% of portfolio
Bellevue Group Ag Kuesnacht, V8

8.52M
Shares

$18.9 Million
0.62% of portfolio
Vestal Point Capital, LP New York, NY

5.03M
Shares

$11.2 Million
1.66% of portfolio
Nea Management Company, LLC Timonium, MD

4.45M
Shares

$9.88 Million
1.48% of portfolio
Black Rock Inc. New York, NY

3.22M
Shares

$7.14 Million
0.0% of portfolio

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $80.7M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account